Related Experiment Videos
The 2-week wait for suspected cancer: time for a rethink?
S J Hanna1, A Muneer, K H Khalil
1Department of General Surgery, Department of Urology, Northampton General Hospital, UK. sjhanna@doctors.net.uk
International Journal of Clinical Practice
|October 21, 2005
Summary
The UK's 2-week cancer referral rule shows mixed results, reducing wait times for some patients but with a low cancer yield and many diagnoses still occurring outside the system. Evidence for improved survival is currently lacking.
Area of Science:
- Oncology
- Healthcare Policy
- Health Services Research
Background:
- The UK introduced the 2-week rule in 2000, mandating specialist appointments for suspected cancer referrals within two weeks.
- This policy aimed to expedite cancer diagnosis and treatment, but its effectiveness remains debated.
- Despite significant literature, a comprehensive review of the 2-week rule's impact was previously unavailable.
Purpose of the Study:
- To conduct a thorough literature review on the implementation and outcomes of the 2-week rule in the UK.
- To synthesize existing evidence regarding waiting times, diagnostic yield, and patient benefits.
- To identify gaps in the evidence, particularly concerning cancer survival rates.
Main Methods:
- A systematic literature review was performed using the MEDLINE database, covering publications from January 2000 onwards.
- Relevant papers were identified through database searches and by examining the reference lists of key articles.
- The review focused on studies evaluating the impact of the 2-week rule on patient pathways and outcomes.
Main Results:
- Some studies indicate a reduction in waiting times for specialist appointments and, in some instances, time to treatment.
- Potential psychological benefits for patients experiencing shorter waits have been noted.
- Concerns persist regarding the low diagnostic yield of malignancy and the significant number of cancers diagnosed outside the 2-week wait pathway.
Conclusions:
- The 2-week rule has demonstrated some success in reducing waiting times for certain cancer referrals.
- However, challenges remain, including a low yield of confirmed malignancies and diagnoses occurring outside the stipulated timeframe.
- Crucially, there is currently no conclusive evidence that the 2-week rule initiative improves overall cancer survival rates.